GURUFOCUS.COM » STOCK LIST » Financial Services » Asset Management » Biotech Growth Trust (The) PLC (LSE:BIOG) » Definitions » Total Assets

Biotech Growth Trust (The) (LSE:BIOG) Total Assets : £411.42 Mil (As of Mar. 2024)


View and export this data going back to 1997. Start your Free Trial

What is Biotech Growth Trust (The) Total Assets?

Biotech Growth Trust (The)'s Total Assets for the quarter that ended in Mar. 2024 was £411.42 Mil.

During the past 12 months, Biotech Growth Trust (The)'s average Total Assets Growth Rate was 14.40% per year. During the past 3 years, the average Total Assets Growth Rate was -14.20% per year. During the past 5 years, the average Total Assets Growth Rate was -2.90% per year. During the past 10 years, the average Total Assets Growth Rate was -0.90% per year.

During the past 13 years, Biotech Growth Trust (The)'s highest 3-Year average Total Assets Growth Rate was 53.60%. The lowest was -14.20%. And the median was 18.15%.

Total Assets is connected with ROA %. Biotech Growth Trust (The)'s annualized ROA % for the quarter that ended in Mar. 2024 was 49.10%. Total Assets is also linked to Revenue through Asset Turnover. Biotech Growth Trust (The)'s Asset Turnover for the quarter that ended in Mar. 2024 was 0.25.


Biotech Growth Trust (The) Total Assets Historical Data

The historical data trend for Biotech Growth Trust (The)'s Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biotech Growth Trust (The) Total Assets Chart

Biotech Growth Trust (The) Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Total Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 401.19 649.53 427.45 360.51 411.42

Biotech Growth Trust (The) Semi-Annual Data
Sep14 Mar15 Sep15 Mar16 Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24
Total Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 427.45 448.49 360.51 308.21 411.42

Biotech Growth Trust (The) Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Biotech Growth Trust (The)'s Total Assets for the fiscal year that ended in Mar. 2024 is calculated as

Total Assets=Total Equity (A: Mar. 2024 )+Total Liabilities (A: Mar. 2024 )
=361.307+50.113
=411.42

Biotech Growth Trust (The)'s Total Assets for the quarter that ended in Mar. 2024 is calculated as

Total Assets=Total Equity (Q: Mar. 2024 )+Total Liabilities (Q: Mar. 2024 )
=361.307+50.113
=411.42

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Biotech Growth Trust (The)  (LSE:BIOG) Total Assets Explanation

Total Assets is connected with ROA %.

Biotech Growth Trust (The)'s annualized ROA % for the quarter that ended in Mar. 2024 is

ROA %=Net Income (Q: Mar. 2024 )/( (Total Assets (Q: Sep. 2023 )+Total Assets (Q: Mar. 2024 ))/ count )
=176.672/( (308.211+411.42)/ 2 )
=176.672/359.8155
=49.10 %

Note: The Net Income data used here is two times the semi-annual (Mar. 2024) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Biotech Growth Trust (The)'s Asset Turnover for the quarter that ended in Mar. 2024 is

Asset Turnover
=Revenue (Q: Mar. 2024 )/( (Total Assets (Q: Sep. 2023 )+Total Assets (Q: Mar. 2024 ))/ count )
=90.849/( (308.211+411.42)/ 2 )
=90.849/359.8155
=0.25

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Biotech Growth Trust (The) Total Assets Related Terms

Thank you for viewing the detailed overview of Biotech Growth Trust (The)'s Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


Biotech Growth Trust (The) (LSE:BIOG) Business Description

Traded in Other Exchanges
Address
25 Southampton Buildings, London, GBR, WC2A 1AL
Biotech Growth Trust (The) PLC is a United Kingdom-based investment trust. Its business objective is to provide its investors with capital appreciation by investing in the biotechnology industry around the world. The company portfolio comprises emerging biotechnology companies across North America, Europe, and Asia, of which North America accounts for the investment share.

Biotech Growth Trust (The) (LSE:BIOG) Headlines

No Headlines